BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBSAL - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBSAL
X-ORIGINAL-URL:https://ibsal.es/en/
X-WR-CALDESC:Events for IBSAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250701
DTEND;VALUE=DATE:20250904
DTSTAMP:20250704T055125Z
CREATED:20250704T055125Z
LAST-MODIFIED:20250704T055125Z
UID:24510-1751328000-1756943999@ibsal.es
SUMMARY:Hairy Cell Leukemia Foundation and Leukemia & Lymphoma Society. Research Grants
DESCRIPTION:Features\nThe Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society have joined forces to invest between $5 million and $7 million over five years in research on hairy cell leukemia (HCL). \nThe purpose of this collaboration is to invest a portion of these funds in research aimed at discovering novel aspects of the biology of classic HCL\, understanding the distinguishing characteristics of the HCL variant (“HCLv”)\, and applying that knowledge in clinical practice; to translate new medical knowledge into clinical applications\, test new treatments in patients through clinical trials\, and use the HCL registry created by HCLF to examine long-term outcomes and their impact on quality of life. \n  \nThis call for applications offers two types of grants: \nLaboratory-to-Clinical Research Grants (LCRGs) \n\nProjects focused on translational research\, including basic research\, in which therapeutic development is of particular importance.\nProjects lasting 3 years\, in which the third year is contingent upon an evaluation of the second year.\nThe maximum amount per year is $250\,000\, including indirect costs.\n\n  \nCollaborative Team Grants (CTGs) \n\nProjects focused on the development and implementation of new clinical trials that can be carried out within the grant’s implementation period.\nFunding is provided for either a single study with supporting research or several coordinated projects that contribute to significant progress in the treatment of HCL.\nGrants with a duration of up to 4 years are funded\, with a maximum amount of $625\,000 per year\, including indirect costs.\n\n\nRequirements\nIf this is your first time applying for assistance from the Leukemia & Lymphoma Society\, the first step is to create an account on their website  at this link. \nThe documents are available on the call for proposals website at this link. \nThe first phase is a letter of intent\, and the deadline is September 3\, 2025\, at 3:00 p.m. \n\nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall for Proposals\nJuly 1\, 2025\n\n\nLetter of Intent Due\nSeptember 3\, 2025\, 3:00 PM (ET)\n\n\nNotification of Invitation to Submit a Full Application\nSeptember 19\, 2025\n\n\nFull Application Deadline\nNovember 21\, 2025\, 3:00 PM (ET)\n\n\nNotification of Awards\nWeek of March 2\, 2026\n\n\nAward Start Date\nApril 1\, 2026\n\n\n\n  \n 
URL:https://ibsal.es/en/evento/hairy-cell-leukemia-foundation-and-leukemia-lymphoma-society-research-grants/
CATEGORIES:Calls for research
END:VEVENT
END:VCALENDAR